Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
IL-22 secreting CD4+ T cells in the patients with neuromyelitis optica and multiple sclerosis.
Idiopathic acute transverse myelitis: Complete recovery after intravenous immunoglobulin.
Retinal Nerve Fiber Layer Thickness, Brain Atrophy, and Disability in Multiple Sclerosis Patients.
Visual issues in multiple sclerosis.
Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy.
Options in improving respiratory function in multiple sclerosis.
Disease-modifying agents in multiple sclerosis.
Antibody-Mediated Inhibition of TNFR1 Attenuates Disease in a Mouse Model of Multiple Sclerosis.
SOCS signaling in autoimmune diseases: molecular mechanisms and therapeutic implications.
Neuromyelitis optica spectrum disorders.
A subtraction pipeline for automatic detection of new appearing multiple sclerosis lesions in longitudinal studies.
Month of birth and the incidence of multiple sclerosis in southern iran.
The Importance of Nitric Oxide and Arginase in the Pathogenesis of Acute Neuroinflammation: Are Those Contra Players with the Same Direction?
Linked in and up to speed.
[Symptomatic therapy in multiple sclerosis].
FTY720 (Fingolimod) sensitizes hepatocellular carcinoma cells to sorafenib-mediated cytotoxicity.
Chronic hepatitis B infection presenting with chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS): a case report.
VIP and PACAP: Neuropeptide modulators of CNS inflammation, injury, and repair.
The perceptions of people with multiple sclerosis about the NHS provision of physiotherapy services.
Treatment-resistant immune thrombocytopenic purpura associated with LDN use in a patient with MS.
Correction: optimal attenuation of experimental autoimmune encephalomyelitis by intravenous immunoglobulin requires an intact interleukin-11 receptor.
Oligoclonal bands in multiple sclerosis patients: worse prognosis?
Clinical, radiographic characteristics and immunomodulating changes in neuromyelitis optica with extensive brain lesions.
Optic neuritis is associated with inner nuclear layer thickening and microcystic macular edema independently of multiple sclerosis.
Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase activating polypeptide (PACAP) in humans with multiple sclerosis.
Pages
« first
‹ previous
…
551
552
553
554
555
556
557
558
559
…
next ›
last »